DNA X, Inc. (SONM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.28M |
| Enterprise Value | 6.04M |
| P/E Ratio | -0.15 |
| PEG Ratio | 0 |
| Price/Sales Ratio | -0.3 |
| Price/Book Ratio | -51.7 |
| Enterprise/Revenue | -0.29 |
| Enterprise/EBITDA | -0.76 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.88 |
| Operating Margin | 0.58 |
AD
Management Effectiveness
| Return On Assets | -3.05 |
| Return On Equity | 6.68 |
Income Statement
| Revenue | 0 |
| Revenue/Share | -13.22 |
| Gross Profit | -4.3M |
| EBITDA | -2.17M |
| Net Income | -20.66M |
| Diluted EPS | -1.59 |
Balance Sheet
| Total Cash | 1.2M |
| Total Cash/Share | 0.94 |
| Total Debt | 1.07M |
| Total Debt/Equity | -12.92 |
| Current Ratio | 0.76 |
| Book Value Per Share | -0.07 |
Price History
| 52-Week Change | -68.91 |
| 52-Week High | 16.97 |
| 52-Week Low | 2.52 |
| Moving Average 50 Days | 4.27 |
| Moving Average 200 Days | 5.54 |
Statistics
| Average Volume | 25,824 |
| Shares Outstanding | 1.49M |
| % Held by Institutions | 7.53 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:18 |
| Last Split Date | October 27, 2025 |
AD
